Desktop Site
|
26 Jul 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
81,332.72
+1,292.92
+1.62 %
Corporate Announcement
Security Code
524816
Company
NATCO PHARMA LTD.
Exchange Received Time
26/07/2024 16:11:37
Exchange Disseminated Time
26/07/2024 16:11:38
Time Taken
00:00:01
Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended June 30, 2024 And Declaration Of Interim Dividend For FY 2024-25, If Any |
7/26/2024 4:11:38 PM
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 ,inter alia, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2024 and declaration of Interim Dividend for FY 2024-25, if any
Attachment
<< Back
Recently Viewed